Korean pharmaceutical industry policy: Lessons for Korea

제목
Korean pharmaceutical industry policy: Lessons for Korea
저자

김대중; Alistair McGuire; Margaret Kyle

키워드
국제공동연구; 보건의료산업
발행연도
2015
발행기관
한국보건사회연구원
초록
The economics of pharmaceutical innovation remains thinnly understood in the research community.
This study discusses the theme of pharmaceutical innovation in terms of government's R&D investment, academic-industrual collaboration, and insurance benefits and pricing.
목차
Abstract 1
Chapter 1. Korean Pharmaceutical Industry and its policy 7
Session 1. Introduction 9
Session 2. Korea’s pharmaceutical industry today 12
Session 3. Direct investment in pharmaceutical R&D by the Koreangovernment 16
Session 4. Academic-industrial collaboration 20
Session 5. Insurance benefits and pricing 23
Session 6. Conclusion 26
Chapter 2. R&D Policy and Pharmaceutical Innovation 29
Session 1. Introduction 31
Session 2. Push and pull policies 33
Session 3. Government funding of R&D in pharmaceuticals 46
Session 4. Conclusion 59
Chapter 3. The Lessons for Korea Arising from the General Regulation on Innovative Health Products 63
Session 1. Background 65
Session 2. DRG pricing 71
Session 3. Value based pricing 76
Session 4. Regulatory Impacts on R&D 93
Session 5. Potential Regulatory Solutions to Lengthening Time toMarket 101
Session 6. Conclusions 105
Reference 109
보고서 번호
연구보고서 2015-37
ISBN
978-89-6827-290-5
Files in This Item:

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

License

Browse